Stock Price
1.63
Daily Change
0.04 2.52%
Monthly
1.24%
Yearly
22.56%
Q2 Forecast
1.60

Autolus Therapeutics Ltd reported $85.73M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
AstraZeneca USD 8.18B 4.35B Mar/2026
Autolus Therapeutics Ltd USD 85.73M 11.02M Mar/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Novartis USD 9.29B 507M Mar/2026
Roche Holding CHF 21.01B 10.84B Dec/2025
Silence Therapeutics USD 12.5M 13.91M Dec/2025